| Financial Year |
March 31 2023 |
| Monetary Funds |
2,998,665,983.79 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
283,260,619.50 |
| Accounts Receivable |
332,494,603.99 |
| Advances to Suppliers |
3,093,500,200.54 |
| Other Receivables |
764,590,074.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
21,448,267,875.46 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
771,687,876.29 |
| Total Current Assets |
29,732,412,773.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
28,997,507.16 |
| Long-term Equity Investment |
5,046,629.01 |
| Investment Properties |
6,735,490,464.99 |
| Fixed Assetes |
551,834,194.76 |
| Under-construction Projects |
23,537,619.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
51,949,468.04 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
955,457,739.16 |
| Other Non-Current Assets |
17,862,421.26 |
| Sub-Total of Non-Current Assets |
8,567,392,085.65 |
| Total Assets |
38,299,804,859.50 |
| Short-Term Loans |
563,782,810.45 |
| Trading Financial liabilities |
-- |
| Notes Payable |
709,241,446.67 |
| Accounts Payable |
2,044,681,593.48 |
| Accounts Received In Advance |
22,182,996.38 |
| Employee Compensation Payable |
86,597,471.63 |
| Taxes Payable |
1,999,041,559.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,909,029,198.19 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,343,612,123.10 |
| Other Current Liabilities |
921,081,007.25 |
| Sub-Total of Current Liabilities |
19,850,905,638.84 |
| Long-term Loans |
3,002,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,764,255,196.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,227,718,222.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,049,007,363.05 |
| Total Liabilities |
25,899,913,001.89 |
| Paid-In Capital(Or Share Stock) |
949,322,474.00 |
| Capital Surplus |
2,398,388,751.96 |
| Surplus Reserve |
638,385,291.82 |
| LESS:Treasury Stock |
204,985,663.63 |
| Undistributed Profits |
6,897,301,670.90 |
| Minority Stockholder's Interest |
1,100,873,628.07 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,299,018,229.54 |
| Owner's Equity（Stockholder's Equity） |
12,399,891,857.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
38,299,804,859.50 |
